Form 4: Arcellx Director Kavita Patel Executes Option and Sells Shares Under 10b5-1 Plan
SEC Form 4
Director Kavita Patel exercised stock options and sold shares of Arcellx, Inc. under a pre-arranged 10b5-1 trading plan.
Summary
- On October 22, 2024, Kavita Patel, a director of Arcellx, Inc., exercised a stock option to acquire 1,500 shares of common stock at a price of $6.66 per share.
- Simultaneously, Ms. Patel sold 1,500 shares of Arcellx common stock at a price of $89.69 per share.
- These transactions were executed under a Rule 10b5-1 trading plan established on March 28, 2024.
- Following these transactions, Ms. Patel continues to beneficially own 60,031 derivative securities (stock options).
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reflects routine insider trading activity under a pre-arranged plan. There is no indication of positive or negative implications for the company.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. The use of a 10b5-1 plan suggests that the insider's trading activity is pre-planned and not based on any material non-public information.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares by a director, but the existence of a 10b5-1 plan mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| March 28, 2024 | Date the Rule 10b5-1 trading plan was entered into by the Reporting Person. |
| October 22, 2024 | Date of the stock option exercise and share sale. |
| December 1, 2021 | Vesting Commencement Date for the stock options. |
| December 7, 2031 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.